Perioperative Chemotherapy with FLOT Improves Survival Among Patients with Resectable Oesophageal Adenocarcinoma By Ogkologos - February 10, 2025 471 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ESOPEC study Source RELATED ARTICLESMORE FROM AUTHOR ESMO’s Special Consultative Status with United Nations Economic and Social Council (UN ECOSOC) Confirmed Until 2028 EMA Recommends Extension of Indications for Selumetinib ESMO Calls for Urgent Changes to the in Vitro Diagnostic Medical Devices Regulation (IVDR) in Order to Safeguard Cancer Research in Europe MOST POPULAR Genomic and Immunophenotypic Heterogeneity of Acquired Resistance to Immune Checkpoint Inhibitors... January 30, 2024 Adagrasib Demonstrates Clinical Activity Across a Broad Range of Tumour Types... May 3, 2023 Patient Exposure to Anticancer Drugs Subsequently Withdrawn from the FDA Accelerated... March 9, 2023 ESMO Calls on EU Research Ministers to Prioritise Cancer Research Funding... September 25, 2025 Load more HOT NEWS Life-saving scheme to improve cancer screening among Muslim women First-Line Treatment with Encorafenib Plus Cetuximab Plus mFOLFOX6 Significantly Improves ORR... One Family’s Mission to Stop Hair Loss from Chemotherapy: Your Stories... Sacituzumab Govitecan Demonstrates Overall Survival Benefit Over Chemotherapy in Patients with...
